It may help to take a break halfway through your meal to check in with yourself to see if youre still hungry
Ecnoglutide is available only as a weekly injection with no oral formulation in development
If weight remains stable for several months, they may try further reduction
Tirzepatide commonly causes nausea (15-25%), diarrhea (12-23%), vomiting (8-11%), constipation (11-17%), and abdominal discomfort, particularly during dose escalation, according to FDA labeling
[1] [2] It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) receptor agonists
Lab values (glucose, cholesterol, triglycerides) often show measurable improvement by this point, which your provider tracks at follow-up visits